Articles Referencing NVS
Good News for Novartis' Ilaris - Analyst Blog
5/15/2013, 6:29 pm from Zacks.com in Investing, Business, Stocks
Novartis ( NVS ) recently
announced that the US Food and Drug Administration (FDA) has
approved Ilaris (canakinumab) for an additional indication.
Ilaris is now approved for the... Read >>
Earnings Beat for PETS, Margins Up - Analyst Blog
5/13/2013, 10:19 am from Zacks.com in Investing, Business, Earnings, Stocks
America's largest pet pharmacy, PetMed Express
( PETS ) reported
earnings of 23 cents per share in the fourth quarter of fiscal
2013, 2 cents ahead of the Zacks Consensus Estimate and up... Read >>
PDL BioPharma Misses Earnings Ests - Analyst Blog
5/13/2013, 10:16 am from Zacks.com in Investing, Business, Earnings, Stocks
PDL BioPharma Inc. ( PDLI ) posted
first-quarter 2013 earnings of 36 cents per share, below the Zacks
Consensus Estimate of 38 cents but ahead of the year-ago figure of
29 cents per share.... Read >>
Pre-Market Most Active for May 10, 2013 : DELL, DDD, APO, NOK, BAC, ING, NVS, PTIE, DNDN, NVDA, ERIC, MU
5/10/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is up 2.22 to 2,963.34. The total
Pre-Market volume is currently 29,565,527 shares traded.
The following are the
most active stocks for the pre-market... Read >>
QLT Narrows Loss - Analyst Blog
5/7/2013, 10:50 am from Zacks.com in Investing, Business, Stocks
QLT Inc. 's ( QLTI ) first quarter
2013 loss of 11 cents per share was narrower than the year-ago loss
of 21 cents per share. The narrower loss was due to the lower costs
incurred by QLT... Read >>
Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 08, 2013
5/7/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
Pfizer, Inc. ( PFE ) will begin
trading ex-dividend on May 08, 2013. A cash dividend payment of
$0.24 per share is scheduled to be paid on June 04, 2013.
Shareholders who purchased PFE stock... Read >>
Narrower-Than-Expected Loss at Incyte - Analyst Blog
5/3/2013, 2:31 pm from Zacks.com in Investing, Business, Stocks
Incyte Corporation ( INCY ) reported a loss
of 12 cents per share in the first quarter of 2013, narrower than
the loss of 13 cents hinted by the Zacks Consensus Estimate. The
company's... Read >>
Pre-Market Most Active for May 3, 2013 : CETV, BAC, ARNA, SPIL, FB, QQQ, AIG, NVS, DB, SIRI, NOK, ABX
5/3/2013, 8:40 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is up 10.37 to 2,921.51. The total
Pre-Market volume is currently 7,627,528 shares traded.
The following are the
most active stocks for the pre-market... Read >>
Earnings Miss at UTHR - Analyst Blog
4/29/2013, 10:04 am from Zacks.com in Investing, Business, Earnings, Stocks
United Therapeutics Corp. ( UTHR ) reported
first-quarter 2013 earnings of $1.19 per share, well below the
year-ago earnings of $1.29 and the Zacks Consensus Estimate of
$1.47. First... Read >>
ImmunoGen Narrows Loss - Analyst Blog
4/29/2013, 9:46 am from Zacks.com in Investing, Business, Stocks
ImmunoGen Inc. ( IMGN ) reported third
quarter fiscal 2013 (ending Mar 31) loss of 2 cents per share,
narrower than the Zacks Consensus Estimate of a loss of 14 cents
and the year-ago... Read >>
Acorda Initiates Study on rHIgM22 - Analyst Blog
4/25/2013, 6:13 pm from Zacks.com in Investing, Business, Stocks
Acorda Therapeutics, Inc. ( ACOR ) and Mayo Clinic
announced the enrollment of the first patient in a phase I safety
study of rHIgM22. rHIgM22, a remyelinating monoclonal antibody, is
being... Read >>
FDA Designation for Merck Candidate - Analyst Blog
4/25/2013, 5:10 pm from Zacks.com in Investing, Business, Stocks
Merck & Co. Inc. ( MRK ) recently
announced that the US Food and Drug Administration (FDA) granted
breakthrough therapy designation to its oncology candidate,
lambrolizumab... Read >>
InterMune Cuts Loss, Affirms View - Analyst Blog
4/25/2013, 11:10 am from Zacks.com in Investing, Business, Stocks
InterMune Inc .'s ( ITMN ) first-quarter
loss per share of 66 cents was narrower than the Zacks Consensus
Estimate of a loss of 76 cents and the year-ago loss of 75 cents
per share. The... Read >>
Earnings Preview: AmerisourceBergen - Analyst Blog
4/24/2013, 5:10 pm from Zacks.com in Investing, Business, Earnings, Stocks
AmerisourceBergen ( ABC ) is set to report
second quarter 2013 results on Apr 25, 2013. Last quarter, the
company reported in-line results for the first quarter. Let's see
how things are... Read >>
Tax Benefit Boosts Amgen Earnings - Analyst Blog
4/24/2013, 12:56 pm from Zacks.com in Investing, Business, Earnings, Stocks
Amgen ( AMGN ) reported first
quarter 2013 earnings of $1.95 per share, 20 cents above the Zacks
Consensus Estimate and 22.6% above the year-ago earnings. Tax
benefits and a lower share... Read >>